HIF1α and HIF2α independently activate SRC to promote melanoma metastases

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Malignant melanoma exhibits early metastasis via lymphatic and hematogenous routes.
• Hypoxia-inducible factors (HIFs) are upregulated in melanoma, promoting cancer progression and metastasis.
• Hypoxia enhances tumor cell invasiveness by regulating extracellular matrix (ECM) degradation, motility, and adhesion.

Purpose of the Study:

• To investigate the role of HIF1α and HIF2α in melanoma metastasis.
• To elucidate the molecular mechanisms by which HIFs regulate melanoma invasion and ECM remodeling.

Main Methods:

• Utilized a Pten-deficient, Braf-mutant genetically engineered mouse model of melanoma.
• Assessed the impact of HIF1α or HIF2α inactivation on primary tumor formation and metastasis.
• Analyzed the molecular pathways involving PDGFRα, FAK, SRC, MT1-MMP, and MMP2 in HIF-mediated melanoma progression.

Main Results:

• Inactivation of HIF1α or HIF2α abrogated melanoma metastasis without affecting primary tumor formation.
• HIF1α and HIF2α were shown to drive melanoma invasion and invadopodia formation.
• These factors coordinate ECM degradation through MT1-MMP and MMP2 expression, involving PDGFRα and FAK-mediated SRC activation.

Conclusions:

• HIFs are crucial for melanoma progression and metastasis.
• HIF1α and HIF2α activate distinct transcriptional programs that promote metastasis.
• Coordinated regulation of cell invasion and ECM remodeling by HIFs is essential for melanoma spread.